Posted in | eBooks

eBook: Cell-based technologies in drug discovery and Immunotherapy

The cell therapies field has witnessed remarkable advancements in recent years, unlocking new possibilities for treating a wide range of diseases, from cancer to autoimmune disorders. As research continues to push the boundaries of innovation, cell-based approaches are becoming integral to developing next-generation treatments.

Download the eBook

This eBook brings together a curated collection of articles that explore the latest breakthroughs, methodologies, and applications in cell-based research and therapeutics.

The first section explores cell-based assays' critical role in drug discovery, highlighting their impact on accelerating the development of more effective treatments.

Discussions on control types in scientific research and the study of various cell types highlight the importance of robust experimental design and the vast applications of cellular studies.

Insights into disease-state primary cells and tumor-infiltrating lymphocytes also underscore the significance of specialized cell sources in validating and advancing targeted therapies.

Furthermore, this eBook examines the evolving capabilities of next-generation sequencing (NGS) and traces the history and potential of CAR-T cell therapies. Together, these discussions provide a comprehensive overview of the current landscape of cell-based treatments while offering a glimpse into the exciting future of this dynamic field.

Download the eBook

About BioIVT

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.

Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.